ASCO GU 2018: Renal Cell Carcinoma News Program

February 14, 2018

  • Share this post:

This year the ASCO Genitourinary Cancers Symposium took place in San Francisco from February 8th - 10th. In this Renal Cell Carcinoma News Program, we focus on the highlights for RCC at this congress.

Moderator Catherine Hood and a panel of international experts discuss the following topics:

  • Adjuvant systemic therapy
  • Cabozantinib in the first line treatment of metastatic RCC
  • The NIVOREN trial that investigates nivolumab in a ‘real world setting’
  • Combination treatments with VEGF and PD1/PD-L1 inhibition
  • Advances in treatment for papillary RCC


Prof. Joaquim Bellmunt, medical oncologist, Dana-Farber/Brigham and Women's Cancer Center, Boston

Daniel George, medical oncologist, Duke Cancer Center, Durham

Jeanny Aragon-Ching, medical oncologist, Inova Fairfax hospital, Fairfax

Sumanta Pal, medical oncologist, City of Hope Comprehensive Cancer Center, Duarte

Moderator: Catherine Hood

This program is editorially independent and is financially made possible by Bayer and Janssen.